peptide aggregation can cause slow or incomplete deprotection and incomplete coupling - Peptide aggregationprediction aggregation Understanding Peptide Aggregation: Causes, Consequences, and Prevention

Peptide aggregationprediction Peptide aggregation, the process where individual peptide molecules associate to form larger assemblies, is a complex and often problematic phenomenonProtein aggregation is a phenomenon in whichintrinsically-disordered or mis-folded proteins aggregate(ie, accumulate and clump together) either intra- or .... This self-association can occur spontaneously or be triggered by specific environmental conditions, leading to significant challenges in various scientific and industrial applications, particularly in peptide synthesis and therapeutic developmentInvestigating the Mechanism of Peptide Aggregation. Understanding the mechanisms behind peptide aggregation is crucial for controlling and preventing it, ensuring the efficacy and reliability of peptide-based products and research.

The aggregation of peptides is driven by a variety of factors, making it a heterogenous process. While the exact trigger is peptide-specific, common drivers include electrostatic interactions, which play a major role in the self-association of peptides作者：T Garfagnini·2024·被引用次数：10—So-designedpeptidespotently inhibited unrelated proteins aggregating via different mechanisms ranging from amorphousaggregationto Tau and Huntingtin .... The amino acid composition of a peptide is a fundamental determinant of its aggregation propensity.A Peptide Strategy for Inhibiting Different Protein ... For instance, adding aromatic amino acids to the end of a peptide chain can increase its tendency to aggregate, while the placement of charged amino acids can also influence this behavior. In solid-phase peptide synthesis, as peptide chains elongate, they can develop secondary structures that lead to peptide chain aggregation. This aggregation can cause issues such as slow or incomplete deprotection and coupling reactions, effectively hindering the synthesis process by clogging the resin and blocking further chemical reactions.作者：J Wang·2024·被引用次数：18—In this study, we derivecomprehensive aggregation rules for tetrapeptides and pentapeptidesacross the entire sequence space based on the aggregation ...

Factors Influencing Peptide Aggregation

Several factors can influence the physical stability and aggregation of peptides作者：J Wang·2024·被引用次数：18—In this study, we derivecomprehensive aggregation rules for tetrapeptides and pentapeptidesacross the entire sequence space based on the aggregation .... Environmental conditions such as pH, temperature, ionic strength, and the presence of specific excipients can all modulate the aggregation process.Protein aggregation For example, changes in buffer composition, like the concentration of salts or the presence of stabilizing agents like glycerol, can impact a peptide's tendency to aggregate.Evaluation of Peptide/Protein Self-Assembly and ... Researchers are actively investigating the role of electrostatic interactions, metal ions, and post-translational modifications in driving aggregation at a molecular level.

The prediction of peptide aggregation is an active area of research. Advanced computational methods, including machine learning models like PALM, are being developed to predict a peptide's aggregation behavior. These models leverage embeddings from pre-trained protein language models to forecast aggregation, offering valuable insights for peptide design and optimization. Furthermore, kinetic stability measurements are essential for investigating the dynamics of peptide aggregation, providing critical data on how quickly and under what conditions aggregation occurs.

Consequences of Peptide Aggregation

The consequences of peptide aggregation extend beyond synthetic challenges. In the pharmaceutical industry, peptide aggregation propensity is a critical aspect of drug development.作者：G Singh·2008·被引用次数：47—Universal features of the peptide aggregation processsuggest a common mechanism, with a first-order phase transition in aqueous solutions of the peptides ... Aggregated peptides can lose their intended biological activity, become immunogenic, or form insoluble deposits. Protein aggregation, a closely related phenomenon, is known to correlate with numerous human diseases, including neurodegenerative disorders. For example, the aggregation of insoluble amyloid beta (Aβ) peptides in the brain is a hallmark of Alzheimer's disease. Understanding these pathological aggregates, which can vary in structure and shape from amorphous aggregates to more ordered structures like fibrils, is key to developing therapeutic strategies作者：G Singh·2008·被引用次数：47—Universal features of the peptide aggregation processsuggest a common mechanism, with a first-order phase transition in aqueous solutions of the peptides being ....

In therapeutic development, the self-assembly of peptides and proteins is an essential process for various cellular functions, but uncontrolled aggregation can be detrimental. Therapeutic peptides that form aggregates can lead to reduced bioavailability, altered pharmacokinetics, and potential toxicityPeptide Aggregation in Finite Systems: Biophysical Journal. Therefore, strategies to inhibit protein aggregation are of significant interest.作者：K Pagano·2020·被引用次数：134—This review focuses on those natural compounds shown to interfere with Aβaggregationby direct interaction with Aβpeptideand whose inhibitory mechanism has ... These strategies can involve the design of specific peptides that can potently inhibit the aggregation of unrelated proteins through direct interaction, even when those proteins aggregate via different mechanisms. Natural compounds are also being explored for their ability to interfere with peptide aggregation, particularly for amyloid beta peptides implicated in diseases.

Strategies to Prevent and Control Peptide Aggregation

Preventing and controlling peptide aggregation requires a multi-faceted approachProtein Aggregation - an overview | ScienceDirect Topics. In peptide synthesis, strategies to overcome aggregation involve careful selection of amino acids, optimization of coupling and deprotection conditions, and the use of appropriate solvents and resins. For therapeutic peptides, formulation design is paramount.Protein Aggregation - an overview | ScienceDirect Topics This includes selecting appropriate excipients, controlling solution conditions (pH, ionic strength, temperature), and potentially modifying the peptide sequence or structure to reduce its aggregation propensity.

Researchers are exploring various methods to mitigate aggregation, including the development of protein aggregation inhibitors. These can be small molecules, peptides, or even antibodies designed to bind to aggregation-prone regions of proteins and peptides, thereby preventing their self-associationAggregation Rules of Short Peptides | JACS Au. The study of peptide aggregation rules for short peptides, such as tetrapeptides and pentapeptides, provides foundational knowledge for designing peptides with improved stability and reduced aggregation tendencies.

Ultimately, a deep understanding of the molecular mechanisms driving peptide aggregation, coupled with advanced predictive tools and strategic formulation approaches, is essential for harnessing the full potential of peptides in research, medicine, and biotechnology. The ongoing advancements in research, from elucidating aggregation rules at the atomic level to developing sophisticated prediction models, are paving the way for more stable, effective, and reliable peptide-based applications.